BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18338496)

  • 1. Importance of novel sequence alterations in the FHIT gene on formation of breast cancer.
    Ceçener G; Egeli U; Tunca B; Taşdelen I; Tolunay S; Bilgel N
    Tumori; 2007; 93(6):597-603. PubMed ID: 18338496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FHIT gene sequence variants and reduced Fhit protein expression in glioblastoma multiforme.
    Cecener G; Tunca B; Egeli U; Bekar A; Guler G; Tolunay S; Aksoy K
    Cell Mol Neurobiol; 2010 Mar; 30(2):301-7. PubMed ID: 19760177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer.
    Cecener G; Tunca B; Egeli U; Karadag M; Vatan O; Uzaslan E; Tolunay S
    Tumori; 2008; 94(6):845-8. PubMed ID: 19267103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
    Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
    Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer.
    Bekar A; Ceçener G; Tunca B; Guler G; Egeli U; Tolunay S
    Tumori; 2007; 93(6):604-7. PubMed ID: 18338497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
    Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
    Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of FHIT gene methylation in egyptian breast cancer women: association with clinicopathological features.
    Zaki SM; Abdel-Azeez HA; El Nagar MR; Metwally KA; S Ahmed MM
    Asian Pac J Cancer Prev; 2015; 16(3):1235-9. PubMed ID: 25735361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
    Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
    Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of the FHIT and p16 mRNA loss and the K-ras gene mutation in pleural fluids for malignant pleural effusion.
    Li J; Bao QL; Wang Y; Hu YM; Chen P
    Cancer Biomark; 2013; 13(1):49-58. PubMed ID: 23736021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FHIT mutations in human primary gastric cancer.
    Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC
    Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashmir.
    Syeed N; Husain SA; Sameer AS; Chowdhri NA; Siddiqi MA
    Mutat Res; 2011 Feb; 707(1-2):1-8. PubMed ID: 21095196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in the fragile histidine triad (FHIT) locus and expression analysis of FHIT protein in patients with breast disorders.
    Rabelo RA; Antunes LM; Etchebehere RM; Nomelini RS; Nascentes GA; Murta EF; Pedrosa AL
    Clin Exp Obstet Gynecol; 2013; 40(1):89-94. PubMed ID: 23724516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene mutations in esophageal mucosa of chagas disease patients.
    DA Silva Manoel-Caetano F; Silveira AF; Silva AE
    Anticancer Res; 2009 Apr; 29(4):1243-7. PubMed ID: 19414370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutations of the STK11 and FHIT genes among patients with Peutz-Jeghers syndrome].
    Mao X; Zhang Y; Wang H; Mao G; Ning S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):186-90. PubMed ID: 27060312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
    Gatalica Z; Lele SM; Rampy BA; Norris BA
    Cancer; 2000 Mar; 88(6):1378-83. PubMed ID: 10717620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer.
    Sevinc ED; Cecener G; Ak S; Tunca B; Egeli U; Gokgoz S; Tolunay S; Tasdelen I
    Gene; 2016 Sep; 590(2):278-84. PubMed ID: 27236032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
    Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.